Madrigal Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $196.1M | $36.3M |
| FY2022 | $49.3M | $197.4M | $331.5M |
| FY2023 | $115.5M | $405.3M | $99.9M |
| FY2024 | $117.6M | $754.4M | $100.0M |
| FY2025 | $339.9M | $602.7M | $198.7M |